These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
9. In vivo relationship between serotonin 1A receptor binding and gray matter volume in the healthy brain and in major depressive disorder. Zanderigo F; Pantazatos S; Rubin-Falcone H; Ogden RT; Chhetry BT; Sullivan G; Oquendo M; Miller JM; Mann JJ Brain Struct Funct; 2018 Jul; 223(6):2609-2625. PubMed ID: 29550938 [TBL] [Abstract][Full Text] [Related]
10. Higher in vivo serotonin-1a binding in posttraumatic stress disorder: a PET study with [11C]WAY-100635. Sullivan GM; Ogden RT; Huang YY; Oquendo MA; Mann JJ; Parsey RV Depress Anxiety; 2013 Mar; 30(3):197-206. PubMed ID: 23408467 [TBL] [Abstract][Full Text] [Related]
12. Quantification of the Serotonin 1A Receptor Using PET: Identification of a Potential Biomarker of Major Depression in Males. Kaufman J; Sullivan GM; Yang J; Ogden RT; Miller JM; Oquendo MA; Mann JJ; Parsey RV; DeLorenzo C Neuropsychopharmacology; 2015 Jun; 40(7):1692-9. PubMed ID: 25578798 [TBL] [Abstract][Full Text] [Related]
13. Serotonin 1A receptor density measured by F18-Mefway PET/CT in mesiotemporal cortex and raphe does not discriminate therapeutic response in patients with major depressive episode. Barth M; Dunzinger A; Wimmer I; Winkler J; Rittmannsberger H; Nader M; Pichler R Q J Nucl Med Mol Imaging; 2020 Jun; 64(2):203-210. PubMed ID: 29916219 [TBL] [Abstract][Full Text] [Related]
14. Altered serotonin 1A binding in major depression: a [carbonyl-C-11]WAY100635 positron emission tomography study. Parsey RV; Oquendo MA; Ogden RT; Olvet DM; Simpson N; Huang YY; Van Heertum RL; Arango V; Mann JJ Biol Psychiatry; 2006 Jan; 59(2):106-13. PubMed ID: 16154547 [TBL] [Abstract][Full Text] [Related]
15. Will imaging individual raphe nuclei in males with major depressive disorder enhance diagnostic sensitivity and specificity? Pillai RLI; Zhang M; Yang J; Boldrini M; Mann JJ; Oquendo MA; Parsey RV; DeLorenzo C Depress Anxiety; 2018 May; 35(5):411-420. PubMed ID: 29365217 [TBL] [Abstract][Full Text] [Related]
16. Serotonin-1A receptor imaging in recurrent depression: replication and literature review. Drevets WC; Thase ME; Moses-Kolko EL; Price J; Frank E; Kupfer DJ; Mathis C Nucl Med Biol; 2007 Oct; 34(7):865-77. PubMed ID: 17921037 [TBL] [Abstract][Full Text] [Related]
17. Serotonin 1A Receptor Binding of [11C]CUMI-101 in Bipolar Depression Quantified Using Positron Emission Tomography: Relationship to Psychopathology and Antidepressant Response. Lan MJ; Zanderigo F; Pantazatos SP; Sublette ME; Miller J; Ogden RT; Mann JJ Int J Neuropsychopharmacol; 2022 Aug; 25(7):534-544. PubMed ID: 34996114 [TBL] [Abstract][Full Text] [Related]
18. Influence of escitalopram treatment on 5-HT 1A receptor binding in limbic regions in patients with anxiety disorders. Spindelegger C; Lanzenberger R; Wadsak W; Mien LK; Stein P; Mitterhauser M; Moser U; Holik A; Pezawas L; Kletter K; Kasper S Mol Psychiatry; 2009 Nov; 14(11):1040-50. PubMed ID: 18362913 [TBL] [Abstract][Full Text] [Related]
19. Serotonin transporter binding as a possible predictor of one-year remission in major depressive disorder. Miller JM; Oquendo MA; Ogden RT; Mann JJ; Parsey RV J Psychiatr Res; 2008 Oct; 42(14):1137-44. PubMed ID: 18331740 [TBL] [Abstract][Full Text] [Related]
20. Altered Serotonin 1B Receptor Binding After Escitalopram for Depression Is Correlated With Treatment Effect. Gärde M; Matheson GJ; Varnäs K; Svenningsson P; Hedman-Lagerlöf E; Lundberg J; Farde L; Tiger M Int J Neuropsychopharmacol; 2024 May; 27(5):. PubMed ID: 38695786 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]